| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1039422578 |
| P356 | DOI | 10.1038/SJ.ONC.1203456 |
| P698 | PubMed publication ID | 10734315 |
| P5875 | ResearchGate publication ID | 12582528 |
| P2093 | author name string | S Sukumar | |
| A T Ferguson | |||
| N Sacchi | |||
| R Orlandi | |||
| E Sironi | |||
| S Subramanyan | |||
| S M Sirchia | |||
| P2860 | cites work | Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene | Q24300919 |
| Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex | Q24324026 | ||
| CpG methylation, chromatin structure and gene silencing-a three-way connection | Q24533302 | ||
| Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands | Q24631957 | ||
| CpG-rich islands and the function of DNA methylation | Q28131800 | ||
| Genomic organization of the human retinoic acid receptor beta 2 | Q28212852 | ||
| Mouse and human retinoic acid receptor beta 2 promoters: sequence comparison and localization of retinoic acid responsiveness | Q28236548 | ||
| Role of the histone deacetylase complex in acute promyelocytic leukaemia | Q28263534 | ||
| Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer | Q29615066 | ||
| Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia | Q29616211 | ||
| DNA methylation and chromatin modification. | Q33632335 | ||
| Histone deacetylase directs the dominant silencing of transcription in chromatin: association with MeCP2 and the Mi-2 chromodomain SWI/SNF ATPase | Q33671506 | ||
| Retinoid receptors in health and disease: co-regulators and the chromatin connection | Q33707446 | ||
| Relationships between chromatin organization and DNA methylation in determining gene expression | Q33765668 | ||
| Retinoids in cancer therapy | Q36032204 | ||
| Retinoic acid receptor beta mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells | Q36557548 | ||
| Distinct retinoid X receptor-retinoic acid receptor heterodimers are differentially involved in the control of expression of retinoid target genes in F9 embryonal carcinoma cells | Q36568500 | ||
| Retinoid-induced chromatin structure alterations in the retinoic acid receptor beta2 promoter | Q36573538 | ||
| A histone deacetylase inhibitor potentiates retinoid receptor action in embryonal carcinoma cells | Q36592145 | ||
| Core histone hyperacetylation co-maps with generalized DNase I sensitivity in the chicken beta-globin chromosomal domain. | Q37631005 | ||
| Retinoid-dependent in vitro transcription mediated by the RXR/RAR heterodimer | Q38301241 | ||
| Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function | Q40547910 | ||
| Signal relay by retinoic acid receptors alpha and beta in the retinoic acid-induced expression of insulin-like growth factor-binding protein-3 in breast cancer cells | Q40949122 | ||
| Activation of the retinoic acid receptor beta gene by 5-aza-2'-deoxycytidine in human DLD-1 colon carcinoma cells | Q41139729 | ||
| DNA methylation models histone acetylation | Q44585032 | ||
| DNA methylation affects the formation of active chromatin | Q44614953 | ||
| Demethylation of the progesterone receptor CpG island is not required for progesterone receptor gene expression | Q47684706 | ||
| Structure of the human retinoic acid receptor beta 1 gene. | Q48057964 | ||
| Different ligand responsiveness of human retinoic-acid-receptor beta-gene transcription in tumorigenic and non-tumorigenic cervical-carcinoma-derived cell lines is mediated through a large retinoic-acid-response domain | Q48062012 | ||
| Promoter architecture, cofactors, and orphan receptors contribute to cell-specific activation of the retinoic acid receptor beta2 promoter. | Q52182194 | ||
| Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase. | Q54117344 | ||
| Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL. | Q54147247 | ||
| Absence of microsatellite instability in breast carcinomas with both p53 and c-erbB-2 alterations | Q61910329 | ||
| Retinoic acid nuclear receptor beta inhibits breast carcinoma anchorage independent growth | Q71825050 | ||
| Retinoic acid receptor expression abnormalities in lung cancer: important clues or major obstacles? | Q73337245 | ||
| Repression of transactivation of the retinoic acid receptor beta2 promoter in human breast cancer cells | Q77598277 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | tretinoin | Q29417 |
| P304 | page(s) | 1556-1563 | |
| P577 | publication date | 2000-03-01 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor beta2 promoter in breast cancer cells | |
| P478 | volume | 19 |
| Q33612962 | 5-Aza-2-deoxycytidine and trichostatin A increase COUP-TFII expression in antiestrogen-resistant breast cancer cell lines |
| Q33880963 | A DNA methyltransferase inhibitor and all-trans retinoic acid reduce oral cavity carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide |
| Q39833989 | A modified protocol for bisulfite genomic sequencing of difficult samples. |
| Q54355290 | Aberrant methylation of cyclooxygenase-2 in breast cancer patients. |
| Q82539025 | Accumulation of DNA methylation is associated with tumor stage in gastric cancer |
| Q43839577 | Allelic loss of chromosome 3p24 correlates with tumor progression rather than with retinoic acid receptor beta2 expression in breast carcinoma |
| Q39956276 | Allelic methylation bias of the RARB2 tumor suppressor gene promoter in cancer. |
| Q37903910 | An overview of the molecular pathology of head and neck cancer, and its clinical implications. |
| Q40453415 | Analysis of methylation-sensitive transcriptome identifies GADD45a as a frequently methylated gene in breast cancer. |
| Q24816725 | Antimetastatic gene expression profiles mediated by retinoic acid receptor beta 2 in MDA-MB-435 breast cancer cells |
| Q34709370 | Assessment of DNA methylation status in early stages of breast cancer development |
| Q53721508 | Association of folate and other one-carbon related nutrients with hypermethylation status and expression of RARB, BRCA1, and RASSF1A genes in breast cancer patients. |
| Q28345689 | Biallelic inactivation of retinoic acid receptor beta2 gene by epigenetic change in breast cancer |
| Q37536680 | Blocking the PAH2 domain of Sin3A inhibits tumorigenesis and confers retinoid sensitivity in triple negative breast cancer |
| Q38356593 | CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells |
| Q24806085 | Chemically induced DNA hypomethylation in breast carcinoma cells detected by the amplification of intermethylated sites |
| Q35108777 | Chemoprevention of Tumors: The Role of RAR-Beta |
| Q36918202 | Combined Treatment with Epigenetic, Differentiating, and Chemotherapeutic Agents Cooperatively Targets Tumor-Initiating Cells in Triple-Negative Breast Cancer |
| Q35863615 | Comparative cytotoxicity of artemisinin and cisplatin and their interactions with chlorogenic acids in MCF7 breast cancer cells |
| Q37155719 | CpG island tumor suppressor promoter methylation in non-BRCA-associated early mammary carcinogenesis |
| Q34220062 | DNA hypermethylation and histone hypoacetylation of the HLTF gene are associated with reduced expression in gastric carcinoma |
| Q34770599 | DNA methylation and breast carcinogenesis. |
| Q44970194 | DNA methylation control of tissue polarity and cellular differentiation in the mammary epithelium |
| Q34274795 | DNA methylation of RASSF1A, HIN‐1, RAR‐β, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma |
| Q34446604 | DNA methylation of genes linked to retinoid signaling in squamous cell carcinoma of the esophagus: DNA methylation of CRBP1 and TIG1 is associated with tumor stage |
| Q34447242 | DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation |
| Q34544990 | DNA methylation of nuclear receptor genes--possible role in malignancy |
| Q96340779 | DNA methylation patterns of RAR-β2 and RASSF1A gene promoters in FNAB samples from Greek population with benign or malignant breast lesions |
| Q33403253 | Derangement of a factor upstream of RARalpha triggers the repression of a pleiotropic epigenetic network |
| Q73852496 | Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR |
| Q38306563 | Development of a novel approach for breast cancer prediction and early detection using minimally invasive procedures and molecular analysis: how cytomorphology became a breast cancer risk predictor |
| Q43785798 | Differential effects of chromosome 3p deletion on the expression of the putative tumor suppressor RAR beta and on retinoid resistance in human squamous carcinoma cells |
| Q44124486 | Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas |
| Q34557361 | Dominant negative retinoic acid receptor initiates tumor formation in mice |
| Q44733985 | Downregulation of gelsolin and retinoic acid receptor beta expression in gastric cancer tissues through histone deacetylase 1. |
| Q55007013 | Downregulation of histone demethylase JMJD1C inhibits colorectal cancer metastasis through targeting ATF2. |
| Q38364206 | Downstream codons in the retinoic acid receptor beta -2 and beta -4 mRNAs initiate translation of a protein isoform that disrupts retinoid-activated transcription |
| Q24794407 | Ductal approaches to assessment and management of women at high risk for developing breast cancer |
| Q41888823 | Epigenetic changes during hematopoietic cell granulocytic differentiation--comparative analysis of primary CD34+ cells, KG1 myeloid cells and mature neutrophils |
| Q34334842 | Epigenetic downregulation of the retinoic acid receptor-beta2 gene in breast cancer. |
| Q35014402 | Epigenetic priming of AML blasts for all-trans retinoic acid-induced differentiation by the HDAC class-I selective inhibitor entinostat |
| Q37024069 | Epigenetic regulation as a new target for breast cancer therapy |
| Q34725003 | Epigenetic silencing of cellular retinol-binding proteins in nasopharyngeal carcinoma |
| Q36856318 | Epigenetic targeting in breast cancer: therapeutic impact and future direction |
| Q37078784 | Epigenomics and breast cancer |
| Q37310981 | Familial and racial determinants of tumour suppressor genes promoter hypermethylation in breast tissues from healthy women. |
| Q35749369 | Gene promoter hypermethylation in ductal lavage fluid from healthy BRCA gene mutation carriers and mutation-negative controls |
| Q41664067 | Histone Deacetylases as New Therapeutic Targets in Triple-negative Breast Cancer: Progress and Promises |
| Q40488993 | Identification of novel RARbeta2 transcript variants with short 5'-UTRs in normal and cancerous breast epithelial cells |
| Q34150792 | Impaired retinoic acid (RA) signal leads to RARbeta2 epigenetic silencing and RA resistance |
| Q59804079 | Induction of cell cycle arrest and inflammatory genes by combined treatment with epigenetic, differentiating, and chemotherapeutic agents in triple-negative breast cancer |
| Q37626858 | Inhibition of PRC2 histone methyltransferase activity increases TRAIL-mediated apoptosis sensitivity in human colon cancer cells |
| Q51776655 | Isolation and comparative study of cell-free nucleic acids from human urine. |
| Q39531093 | Knockdown of RARB2 identifies a dual role in cancer |
| Q44588824 | Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors |
| Q59504124 | Loss of heterozygosity of the NOS3 dinucleotide repeat marker in atherosclerotic plaques of human carotid arteries |
| Q38450120 | Methylation Profiling of Benign and Malignant Breast Lesions and Its Application to Cytopathology |
| Q74234880 | Methylation of conserved CpG sites neighboring the beta retinoic acid response element may mediate retinoic acid receptor beta gene silencing in MCF-7 breast cancer cells |
| Q34267943 | Methylation patterns in cell-free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patients |
| Q36745391 | Molecular pathways: current role and future directions of the retinoic acid pathway in cancer prevention and treatment |
| Q35653852 | Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours |
| Q36607318 | Polycyclic aromatic hydrocarbon (PAH)-DNA adducts and breast cancer: modification by gene promoter methylation in a population-based study |
| Q37606299 | Prognostic and therapeutic potential of nuclear receptors in head and neck squamous cell carcinomas |
| Q36622838 | Prognostic significance of gene-specific promoter hypermethylation in breast cancer patients |
| Q91669240 | Promoter Methylation Status of the Retinoic Acid Receptor-Beta 2 Gene in Breast Cancer Patients: A Case Control Study and Systematic Review |
| Q57890923 | Promoter Methylation and Silencing of the Retinoic Acid Receptor- Gene in Lung Carcinomas |
| Q35801560 | Promoter Methylation of the Retinoic Acid Receptor Beta2 (RARβ2) Is Associated with Increased Risk of Breast Cancer: A PRISMA Compliant Meta-Analysis |
| Q40356013 | RAR-mediated epigenetic control of the cytochrome P450 Cyp26a1 in embryocarcinoma cells |
| Q91727275 | Retinoic Acid Receptors in Acute Myeloid Leukemia Therapy |
| Q89510543 | Retinoic Acids in the Treatment of Most Lethal Solid Cancers |
| Q39929691 | Retinoic acid receptor beta2 re-expression and growth inhibition in thyroid carcinoma cell lines after 5-aza-2'-deoxycytidine treatment. |
| Q35867945 | Retinoic acid reduces migration of human breast cancer cells: role of retinoic acid receptor beta |
| Q38240617 | Retinoic acid signaling in cancer: The parable of acute promyelocytic leukemia |
| Q38331050 | Retinoic acid targets DNA-methyltransferases and histone deacetylases during APL blast differentiation in vitro and in vivo. |
| Q35009313 | Retinoid, retinoic acid receptor beta and breast cancer |
| Q34498098 | Retinoids and their receptors in cancer development and chemoprevention |
| Q28081010 | Retinoids induce cellular senescence in breast cancer cells by RAR-β dependent and independent pathways: Potential clinical implications (Review) |
| Q37809078 | Retinoids, Retinoic Acid Receptors, and Cancer |
| Q35053227 | Selective retinoids and rexinoids in cancer therapy and chemoprevention |
| Q34000367 | Synergistic chromatin repression of the tumor suppressor gene RARB in human prostate cancers |
| Q42446700 | The N-terminal of the estrogen receptor (ERalpha) mediates transcriptional cross-talk with the retinoic acid receptor in human breast cancer cells |
| Q26772035 | The Role of Sulforaphane in Epigenetic Mechanisms, Including Interdependence between Histone Modification and DNA Methylation |
| Q35053948 | The biology of breast carcinoma |
| Q35623919 | The influence of one-carbon metabolism on gene promoter methylation in a population-based breast cancer study. |
| Q37197352 | The methylation of the TSC2 promoter underlies the abnormal growth of TSC2 angiomyolipoma-derived smooth muscle cells |
| Q43675656 | The role of epigenetic modifications in retinoic acid receptor beta2 gene expression in human prostate cancers |
| Q36932335 | Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RARβ and tumor regression |
| Q58862234 | Total synthesis of the proposed structures of the DNA methyl transferase inhibitors peyssonenynes, and structural revision of peyssonenyne B |
| Q37699371 | Tracing anti-cancer and cancer-promoting actions of all-trans retinoic acid in breast cancer to a RARα epigenetic mechanism of mammary epithelial cell fate |
| Q39570650 | Valproic acid: growth inhibition of head and neck cancer by induction of terminal differentiation and senescence. |
Search more.